RANI THERAPEUTICS HOLDINGS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.23 USD | -3.64% |
|
-8.97% | +28.31% |
Chart calendar Rani Therapeutics Holdings, Inc.
ba052239c569bba.bu2bFEUy7oyl_uisX7SNEwzyXqPvKJwNRtUv2aRZjvE.XtrBZQ0Ao9vhloKecufEcmiXDdCpR61BKuV4ssASyIdehfEjLkWFutWQ3A~4c2d4dc076220de349a0972731a982b2
Upcoming events on Rani Therapeutics Holdings, Inc.
Past events on Rani Therapeutics Holdings, Inc.
| 2024-05-29 11:00 am | Annual General Meeting |
| 2024-05-21 12:30 pm | Digestive Disease Week Conference - Poster No - Tu1729 |
| 2024-05-20 | UBS Spring Biotech Conference |
| 2024-05-20 02:30 pm | H.C. Wainwright BioConnect Investor Conference |
| 2024-05-19 03:00 pm | Digestive Disease Week Conference - Abstract No - 3465 |
| 2024-05-06 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-20 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-20 04:05 pm | Q4 2023 Earnings Release |
| 2024-02-05 08:30 am | RT-111 Phase 1 Clinical Trial Results Call |
| 2023-11-08 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-14 04:30 pm | American Society for Bone and Mineral Research Meeting - Presentation No: SAT-435 |
| 2023-09-28 08:35 am | Cantor Global Healthcare Conference |
| 2023-09-11 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-11 04:05 pm | Q2 2023 Earnings Release |
| 2023-08-10 01:00 pm | Canaccord Genuity Growth Conference |
| 2023-08-07 | Wedbush PacGrow Healthcare Conference |
| 2023-08-07 02:00 pm | BTIG Virtual Biotechnology Conference |
| 2023-06-08 04:00 pm | Jefferies Global Healthcare Conference |
| 2023-05-25 11:00 am | Annual General Meeting |
| 2023-05-10 04:05 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 2,72 2,92 -7.03% | 0,00 0,11 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -51,1 -57,3 10.76% | -62,9 -61,2 -2.82% | -65,3 -71,0 8.03% | -61,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -51,6 -54,0 4.44% | -63,5 -63,3 -0.28% | -66,1 -69,8 5.26% | -55,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -53,0 -50,9 -4.32% | -63,3 -64,4 1.7% | -67,9 -70,2 3.34% | -54,8 |
|
Net income Million USD | Released Forecast Spread | -16,7 | -8,33 -50,9 83.63% | -30,6 -45,0 32.08% | -34,0 -35,4 3.98% | -29,3 |
|
EPS USD | Released Forecast Spread | -0,36 | -0,43 -1,11 61.09% | -1,28 -1,27 -0.46% | -1,33 -1,37 2.56% | -1,00 |
| Announcement Date | 27/04/21 | 31/03/22 | 22/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,33 - | 0,00 0,13 - | 0,00 0,13 - | 0,00 0,11 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -13,7 -19,0 27.92% | -15,7 -23,3 32.62% | -16,2 -18,6 13.12% | -17,3 -14,9 -16.01% | -16,3 -16,7 2.44% | -18,1 -18,3 1.09% | -17,6 -18,7 5.72% | -13,2 -18,3 27.87% | -13,8 -14,2 2.81% | -16,2 | -16,1 | -15,0 | ||
|
EBIT Million USD | Released Forecast Spread | -13,8 -17,7 22.29% | -15,8 -17,3 8.39% | -16,3 -17,6 6.94% | -17,5 -17,1 -2% | -16,5 -18,2 9.01% | -18,3 -18,2 -0.35% | -17,9 -19,5 8.62% | -13,4 -17,0 21.15% | -14,0 -13,4 -4.44% | -14,4 | -14,4 | -14,1 | -7,25 | -17,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,8 -16,5 16.58% | -15,8 -15,9 0.52% | -16,3 -17,2 4.9% | -17,4 -18,4 5.33% | -16,8 -18,5 9.16% | -18,7 -17,9 -4.1% | -18,3 -20,3 9.72% | -14,1 -16,6 15.41% | -14,8 -13,9 -6.53% | -13,8 | -14,1 | -13,9 | -8,00 | -18,2 |
|
Net income Million USD | Released Forecast Spread | -6,22 -16,5 62.28% | -7,62 -11,4 33.21% | -7,96 -9,84 19.18% | -8,79 -11,0 20.28% | -8,37 -11,5 27.4% | -9,30 -13,8 32.39% | -9,20 -14,4 36.21% | -7,10 -8,51 16.58% | -7,48 -6,94 -7.81% | -7,16 | -7,27 | -7,36 | -0,70 | -10,9 |
|
EPS USD | Released Forecast Spread | -0,29 -0,32 9.38% | -0,31 -0,37 15.65% | -0,33 -0,47 29.47% | -0,35 -0,35 -0.31% | -0,33 -0,43 23.21% | -0,37 -0,41 9.46% | -0,36 -0,38 5.88% | -0,27 -0,31 12.9% | -0,29 -0,20 -42.63% | -0,27 | -0,27 | -0,24 | ||
| Announcement Date | 11/05/22 | 10/08/22 | 10/11/22 | 22/03/23 | 10/05/23 | 11/08/23 | 08/11/23 | 20/03/24 | 06/05/24 | - | - | - | - | - |
More events
Past sector events for Rani Therapeutics Holdings, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RANI Stock
- Calendar Rani Therapeutics Holdings, Inc.
